Three people speaking at a panel
Pulmonary & Critical Care Medicine Research

Research performed within the U-M Medical School Department of Internal Medicine Division of Pulmonary & Critical Care Medicine has greatly impacted our understanding of basic lung biology, disease pathogenesis and targeted therapeutics. 

NIH grant funding for research within the Division exceeds 13 million dollars annually. Our investigative portfolio is comprehensive, with specific areas of emphasis including pulmonary inflammation, lung injury and repair, fibrotic lung disorders, host defense, lung transplantation, and lung cancer.

New major areas of modern biology have emerged, including genetics/genomics, metagenomics, proteomics, metabolomics, stem cell biology, computational biology, and the microbiome. Researchers in the division participate in large multidisciplinary and multicenter disease-specific programs and networks in interstitial lung disease (IPFnet, COMET, LTRC), COPD (SPIROMICS, COPD gene, LTRC), and Acute Lung Injury (SCOR, SCCOR, ARDSnet).

Emerging fields of patient-oriented research have been added or expanded, including health services research and sleep. Active areas of health services research include long-term functional outcomes in survivors of critical illness, nosocomial infection, delirium in the ICU, health care utilization and health care policy.

Areas of Research
  • Cancer
  • Chronic Obstructive Pulmonary Disease
  • Critical Care
  • Fibrotic Lung Disease
  • Health Services, Outcomes & Policy Program
  • Lung Injury & Repair Reseach
  • Lung Transplantation & Stem Cell Biology Program
  • Multidisciplinary Intensive Care Research Workgroup (MICReW)
  • Microbiome Program
  • Pulmonary Immunity
  • Severe Asthma
    • Featured News & Stories See all news floating AI-type images in red and blues and yellow on blue background
    Health Lab
    Racial differences in medical testing could introduce bias to AI models
    Black patients are less likely than white patients to receive certain medical tests that doctors use to diagnose severe disease, impacting artificial intelligence data. But researchers have found a way to correct the bias in these data sets.
         young adult man standin infront of welcome to michigan yellow sign and a photo next to that one of him sitting with a man standing next to him in glasses and UM badge and button down light blue shirt
    Health Lab
    Timely CPR saves runner who collapsed during first week of college
    Bystander CPR saves a first year college student who collapsed from sudden cardiac arrest while running during his first week of school.
         man walking on treadmill in open space with person in blue scrubs and scrub hat
    Health Lab
    Less than 1% of COPD patients receive pulmonary rehab following hospitalization
    Rehabilitation can help patients who are recovering from an injury or illness. However, new data suggests patients hospitalized for chronic obstructive pulmonary disorder, or COPD, aren't receiving it.
         lungs
    Health Lab
    The environmental toll of inhalers for asthma and COPD
    In a JAMA research letter, Medicare and Medicaid claims data were used to estimate the greenhouse gas emissions of inhalers using propellants versus those that are propellant-free in the United States.
         36th Annual Update in Pulmonary & Critical Care Medicine
    Department News
    Update in Pulmonary & Critical Care Medicine CME Course
    Join us for the 36th Annual Update in Pulmonary & Critical Care Medicine taking place on Thursday, September 5 and Friday, September 6, 2024.
         woman smiling with white short hair and earrings dark with orange background
    Health Lab
    Using biologic injections for severe asthma after COVID
    Biologic injections end up being the best treatment for treating severe asthma after having COVID for one patient.